Shangya Technology Co., Ltd. (6130.TWO)
Taipei Exchange · TWD · Healthcare · Drug Manufacturers - General
NT$21.60 (+0.70%) as of
Key statistics
- Market cap
- 1.06B
- EPS (TTM)
- -1.02
- Dividend yield
- 0.00%
- 52-week range
- 20.70 – 48.30
- Beta
- 0.32
- Revenue (TTM)
- 165.3M
- Profit margin
- -27.61%
- Volume
- 52.03k
About Shangya Technology Co., Ltd.
Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It is also involved in the research, development, production, and sale of wireless communication integrated circuits, satellite positioning system integrated circuits, and portable product ICs. The company was formerly known as Singbao International Co. Ltd and changed its name to Shangya Technology Co., Ltd. in July 2023. Shangya Technology Co., Ltd. was founded in 1994 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.